Factors affecting the use of salbutamol before hospital admission in children with asthma exacerbation.

IF 2.5 4区 医学 Q3 ALLERGY
Allergologia et immunopathologia Pub Date : 2024-11-01 eCollection Date: 2024-01-01 DOI:10.15586/aei.v52i6.1178
Ilknur Kulhas Celik, Hakan Guvenir, Betul Buyuktiryaki, Ozge Yilmaz Topal, Emine Dibek Misirlioglu, Muge Toyran, Can Naci Kocabas, Ersoy Civelek
{"title":"Factors affecting the use of salbutamol before hospital admission in children with asthma exacerbation.","authors":"Ilknur Kulhas Celik, Hakan Guvenir, Betul Buyuktiryaki, Ozge Yilmaz Topal, Emine Dibek Misirlioglu, Muge Toyran, Can Naci Kocabas, Ersoy Civelek","doi":"10.15586/aei.v52i6.1178","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Early home intervention for asthma exacerbation (AE) in children is associated with more favorable outcomes. Inhaled short-acting beta<sub>2</sub> agonists (SABA) are the cornerstones of AE treatment.</p><p><strong>Objectives: </strong>We aimed to determine what proportion of parents administered salbutamol to their children to treat asthma exacerbation at home, and the factors affecting the decision to administer the medication. Additionally, we also aimed to examine the parents' level of knowledge regarding salbutamol use.</p><p><strong>Methods: </strong>Asthma patients who were admitted to pediatric allergy outpatient clinics due to AE were included in the study. Parents' knowledge related to home salbutamol use was evaluated using a questionnaire. Modified Pulmonary Index Score was used to evaluate AE severity.</p><p><strong>Results: </strong>The study included 177 children (64.4% males) with a median age of 6.16 years. Of these, 86 patients (48.6%) had not administered salbutamol before hospital admission, and parents of 69 (80%) patients stated that they knew salbutamol should be administered but they did not want to administer it without consulting a doctor. Of the 91 patients who had used salbutamol before hospital admission, 28 (30.7%) had administered the incorrect dose, 2 (2.2%) used the incorrect technique, and 9 (9.9%) had the incorrect dose and incorrect technique. In multivariate logistic regression analysis, history of hospitalizations (odds ratio [OR]: 6.35; 95% confidence interval [CI]: 3.07-13.9; P < 0.001), history of more than five exacerbations (OR: 4.51, 95%CI: 1.94-10.48; P < 0.001 ), and presence of sputum (OR: 2.54; 95%CI: 1.10-5.87; P = 0.028) were the main predictors of salbutamol use.</p><p><strong>Conclusion: </strong>Asthma patients and their parents should be better educated and actively encouraged on the use of SABA at home during an AE.</p>","PeriodicalId":7536,"journal":{"name":"Allergologia et immunopathologia","volume":"52 6","pages":"1-8"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergologia et immunopathologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15586/aei.v52i6.1178","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Early home intervention for asthma exacerbation (AE) in children is associated with more favorable outcomes. Inhaled short-acting beta2 agonists (SABA) are the cornerstones of AE treatment.

Objectives: We aimed to determine what proportion of parents administered salbutamol to their children to treat asthma exacerbation at home, and the factors affecting the decision to administer the medication. Additionally, we also aimed to examine the parents' level of knowledge regarding salbutamol use.

Methods: Asthma patients who were admitted to pediatric allergy outpatient clinics due to AE were included in the study. Parents' knowledge related to home salbutamol use was evaluated using a questionnaire. Modified Pulmonary Index Score was used to evaluate AE severity.

Results: The study included 177 children (64.4% males) with a median age of 6.16 years. Of these, 86 patients (48.6%) had not administered salbutamol before hospital admission, and parents of 69 (80%) patients stated that they knew salbutamol should be administered but they did not want to administer it without consulting a doctor. Of the 91 patients who had used salbutamol before hospital admission, 28 (30.7%) had administered the incorrect dose, 2 (2.2%) used the incorrect technique, and 9 (9.9%) had the incorrect dose and incorrect technique. In multivariate logistic regression analysis, history of hospitalizations (odds ratio [OR]: 6.35; 95% confidence interval [CI]: 3.07-13.9; P < 0.001), history of more than five exacerbations (OR: 4.51, 95%CI: 1.94-10.48; P < 0.001 ), and presence of sputum (OR: 2.54; 95%CI: 1.10-5.87; P = 0.028) were the main predictors of salbutamol use.

Conclusion: Asthma patients and their parents should be better educated and actively encouraged on the use of SABA at home during an AE.

影响哮喘加重儿童入院前使用沙丁胺醇的因素。
背景:对儿童哮喘加重(AE)进行早期家庭干预可获得更好的治疗效果。吸入短效β2受体激动剂(SABA)是治疗哮喘加重的基石:我们旨在确定有多大比例的家长会在家中给孩子使用沙丁胺醇治疗哮喘加重,以及影响用药决定的因素。此外,我们还希望了解家长对使用沙丁胺醇的了解程度:研究对象包括因哮喘发作而到儿科过敏门诊就诊的哮喘患者。采用问卷调查的方式评估家长对在家中使用沙丁胺醇的相关知识。改良肺指数评分用于评估AE的严重程度:研究包括 177 名儿童(64.4% 为男性),中位年龄为 6.16 岁。其中,86 名患者(48.6%)在入院前未使用过沙丁胺醇,69 名患者(80%)的家长表示他们知道应该使用沙丁胺醇,但他们不想在未咨询医生的情况下使用沙丁胺醇。在入院前使用过沙丁胺醇的 91 名患者中,28 人(30.7%)使用了错误的剂量,2 人(2.2%)使用了错误的技术,9 人(9.9%)使用了错误的剂量和错误的技术。在多变量逻辑回归分析中,住院史(几率比[OR]:6.35;95% 置信区间[CI]:3.07-13.9;P <0.001)、5 次以上病情加重史(OR:4.51;95% 置信区间[CI]:1.94-10.48;P <0.001)和有痰(OR:2.54;95% 置信区间[CI]:1.10-5.87;P =0.028)是使用沙丁胺醇的主要预测因素:结论:应加强对哮喘患者及其家长的教育,并积极鼓励他们在哮喘发作时在家使用沙丁胺醇。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
131
审稿时长
6-12 weeks
期刊介绍: Founded in 1972 by Professor A. Oehling, Allergologia et Immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. Manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. Allergologia et Immunopathologia is the official journal of the Spanish Society of Pediatric Allergy and Clinical Immunology (SEICAP) and also of the Latin American Society of Immunodeficiencies (LASID). It has and independent international Editorial Committee which submits received papers for peer-reviewing by international experts. The journal accepts original and review articles from all over the world, together with consensus statements from the aforementioned societies. Occasionally, the opinion of an expert on a burning topic is published in the "Point of View" section. Letters to the Editor on previously published papers are welcomed. Allergologia et Immunopathologia publishes 6 issues per year and is included in the major databases such as Pubmed, Scopus, Web of Knowledge, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信